AI and Lab Data: Enabling Decision-Making in Real Time

#artificialintelligence 

Lisa KerberBig data and Artificial Intelligence (AI) undoubtedly have begun disrupting how the business of healthcare is done. As a result, information is available in near real-time as are the business insights derived from it. For pharmaceutical organizations, this means they can now depend on real-time and forward-looking data versus historical data in decision-making, informing timely actions to benefit the patient. Today, the pharma industry can take advantage of new clinical data sources such as diagnostics, or lab data, combined with AI to deliver on the promise of improving outcomes. With these new tools, pharma can tailor its efforts to deliver the right therapy to the right patient at the right time.